In Stock
Gefitinib Tablets
Gefitinib Tablets 250mg | Anti-Cancer
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic medicine information • Updated 16 October 2026
Important: This is an educational guide, not a prescription or a substitute for advice from your cancer specialist.
Product Introduction
Gefticip Tablet contains gefitinib 250 mg and is marketed by Cipla Ltd. Gefitinib is a targeted anticancer medicine used for selected patients with non-small cell lung cancer (NSCLC) whose tumour has specific EGFR gene changes.
This is a prescription-only medicine. A specialist will decide whether it is appropriate based on tumour testing, diagnosis, treatment history and the patient’s condition. Do not decide the dose from the tablet strength alone.
1. Uses
Used to treat selected cases of locally advanced or metastatic non-small cell lung cancer with certain activating changes in the epidermal growth factor receptor (EGFR) gene.
Before treatment, the specialist usually confirms whether the tumour has the relevant EGFR mutation. It is not suitable for every type of lung cancer.
2. Benefits
Gefitinib blocks the EGFR tyrosine kinase, interrupting signals that help certain cancer cells grow and divide.
For patients whose tumour is sensitive to gefitinib, it may slow cancer growth or help control the disease. Benefits vary by tumour characteristics and individual response.
3. Side Effects
Common side effects include diarrhoea, skin rash or acne-like changes, dry skin, loss of appetite, nausea, vomiting and mouth irritation or sores.
Seek urgent medical care for new or worsening breathing difficulty, persistent cough or fever; severe or persistent diarrhoea; severe abdominal pain; yellowing of the skin or eyes or dark urine; eye pain or vision changes; or a severe skin reaction.
Rare but serious effects include interstitial lung disease, liver injury, severe diarrhoea, gastrointestinal perforation and serious eye problems. Contact the treating team promptly if symptoms are severe or worsening.
4. Safety Advice
Take only as prescribed by your cancer specialist. Do not change the dose or stop treatment without medical advice.
Your doctor may arrange regular liver-function tests and monitor side effects, hydration and overall response.
Tell your doctor if you have liver disease, eye problems, significant gastrointestinal disease, or take anticoagulants or other regular medicines.
Pregnancy: gefitinib may harm an unborn baby. Tell your doctor if pregnant, planning pregnancy or if pregnancy occurs. Use effective contraception during treatment and for at least 1 month after the last dose, as advised by your specialist.
Breastfeeding is not recommended during treatment; ask your specialist when it may be safe to resume.
Store below 25°C according to the linked product information, and keep out of reach of children. Follow the package leaflet if storage instructions differ.
5. How It Works
Gefitinib is an EGFR tyrosine kinase inhibitor. It blocks signals involved in the growth and division of certain cancer cells, which may slow or stop their progression.
6. How to Use
Follow the exact dose and schedule prescribed by your specialist. Do not use this guide to determine how many tablets to take.
Swallow the tablet whole with water. Do not chew, crush or break it unless a doctor or pharmacist gives specific instructions. It may be taken with or without food, preferably at the same time each day.
Antacids and medicines that reduce stomach acid may affect gefitinib absorption. Check with your doctor or pharmacist before using antacids, H2 blockers or proton-pump inhibitors. Follow their instructions about timing.
If you miss a dose, vomit after taking it, or think you took too much, follow the package leaflet or contact your care team. Do not double a dose unless instructed.
Continue treatment only for as long as your specialist advises.
7. Quick Tips
Take the medicine consistently at the time recommended by your care team.
Drink fluids if diarrhoea occurs. Contact your doctor if diarrhoea does not stop, becomes severe or includes blood.
Report mouth sores, eye pain or vision changes, worsening cough or breathing difficulty promptly.
Keep a current list of prescription medicines, over-the-counter products, vitamins and herbal supplements and share it with your oncology team.
Keep all follow-up appointments and recommended liver-function tests.
8. Drug Interactions
Gefitinib can interact with medicines that affect liver enzymes or stomach acidity. Examples include certain antifungals and antibiotics, rifampicin, some seizure medicines, St John’s wort, and acid-reducing medicines. It may also interact with some cancer medicines and anticoagulants.
Do not start or stop any medicine, supplement or herbal product without checking with your prescriber or pharmacist. This is not a complete interaction list.
Medical Disclaimer
This document is for general educational purposes only and is not a substitute for medical advice, diagnosis or treatment. Gefitinib is a specialist-prescribed anticancer medicine. Do not use this guide to select a dose or make treatment decisions. Always follow the current package leaflet and the instructions of your oncologist or pharmacist. In an emergency, seek urgent medical care.
| Product Name | Gefitinib Tablets |
| Category | All Medicines, Anti Cancer |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 250mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
